Mereo BioPharma Group (MREO) Retained Earnings: 2020-2025
Historic Retained Earnings for Mereo BioPharma Group (MREO) over the last 2 years, with Sep 2025 value amounting to -$493.7 million.
- Mereo BioPharma Group's Retained Earnings fell 8.31% to -$493.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$493.7 million, marking a year-over-year decrease of 8.31%. This contributed to the annual value of -$462.9 million for FY2024, which is 10.31% down from last year.
- Per Mereo BioPharma Group's latest filing, its Retained Earnings stood at -$493.7 million for Q3 2025, which was down 1.45% from -$486.6 million recorded in Q2 2025.
- In the past 5 years, Mereo BioPharma Group's Retained Earnings registered a high of $10.3 million during Q2 2021, and its lowest value of -$493.7 million during Q3 2025.
- Its 3-year average for Retained Earnings is -$457.5 million, with a median of -$459.4 million in 2024.
- As far as peak fluctuations go, Mereo BioPharma Group's Retained Earnings skyrocketed by 70.89% in 2021, and later dropped by 10.39% in 2025.
- Quarterly analysis of 5 years shows Mereo BioPharma Group's Retained Earnings stood at -$400.3 million in 2021, then fell by 1.06% to -$404.6 million in 2022, then dropped by 3.72% to -$419.6 million in 2023, then decreased by 10.31% to -$462.9 million in 2024, then declined by 8.31% to -$493.7 million in 2025.
- Its last three reported values are -$493.7 million in Q3 2025, -$486.6 million for Q2 2025, and -$472.0 million during Q1 2025.